EXPLORING THE EFFECTIVENESS OF CORDYCEPS SINENSIS IN TREATING BRONCHIAL ASTHMA: A PROSPECTIVE STUDY

Abstract

Bronchial asthma is characterized by airway inflammation, hyperreactivity, and reversible airflow obstruction. Traditional Tibetan and Chinese medicines have long used Cordyceps Sinensis for lung-related ailments. This study aims to explore its potential in managing bronchial asthma. This prospective experimental study will include a minimum of 30 cases from in-patients and out-patients of Sri Sai Ram Homoeopathic Medical College and Research Centre and Tambaram Peripheral, Mobile OPD. Diagnostic criteria include clinical presentation, pulmonary function tests, allergic tests, and other relevant investigations. Data were collected from in-patients and out-patients of Sri Sai Ram Homoeopathic Medical College & Research Centre and Tambaram Peripheral Mobile OPD over a period of six months. A minimum of 30 cases were selected based on inclusion criteria, including patients of all age groups and both sexes, diagnosed with bronchial asthma. Exclusion criteria encompassed irreversible diseases and severe chronic lung pathologies. The efficacy of Cordyceps Sinensis was assessed using standard homoeopathic case-taking proforma, Asthma Control Test (ACT), and Asthma Control Questionnaire-6 (ACQ-6). Symptomatic improvement and investigatory findings were utilized for prognostic evaluation. Among the 30 cases included in the study,  44% were men, 33% were women, and 23% were children. Marked improvement was observed in 57% of cases, moderate improvement in 36%, and mild improvement in 7%. This prospective study demonstrates promising results regarding the efficacy of Cordyceps Sinensis 30 in the management of bronchial asthma, indicating its potential as a therapeutic option. Further research is warranted to elucidate its mechanism of action and long-term effects.